市場調查報告書
商品編碼
1578279
全球自體免疫疾病診斷市場研究報告 - 2024 年至 2032 年行業分析、規模、佔有率、成長、趨勢和預測Global Autoimmune Disease Diagnostics Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球自體免疫疾病診斷市場需求預計將從 2023 年的 132 億美元達到 2032 年近 193.5 億美元的市場規模,2024-2032 年研究期間複合年成長率為 4.34%。
免疫系統可以保護身體免受許多細菌、病毒感染和其他疾病的侵害。自體免疫疾病是體內發生的一種不尋常的免疫反應。自體免疫疾病會降低人體抵抗外來顆粒的能力,進而導致攻擊自身組織。自體免疫疾病在女性中比男性更常見。克隆氏症、類風濕性關節炎、發炎性腸道疾病、多發性硬化症、系統性紅斑狼瘡是自體免疫疾病的一些例子。一些醫療中心有許多商業測試可用於診斷自體免疫疾病。
由於政府資助的增加以及診所和診斷中心的合作,全球自體免疫疾病診斷市場預計將成長。除此之外,類風濕性關節炎、格雷夫茲病和橋本甲狀腺病等疾病發生率的上升也推動了市場的成長。此外,對各種自體免疫疾病的認知、醫學領域的進步、實驗室技術的改進等也推動了需求。然而,假陽性結果的高可能性和診斷測試結果的緩慢週轉時間可能會阻礙市場成長。此外,新興市場的發展以及用於疾病預後的新型生物標記的進步可能會為市場成長提供新的機會。
研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外,這些工具也對全球自體免疫疾病診斷市場的各個細分市場進行了包容性評估。自體免疫疾病診斷產業的成長和趨勢為這項研究提供了整體方法。
自體免疫疾病診斷市場報告的這一部分提供了國家和區域層面細分市場的詳細資料,從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。
本節涵蓋區域前景,重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲自體免疫疾病診斷市場當前和未來的需求。此外,該報告重點關注所有主要地區各個應用領域的需求、估計和預測。
該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。自體免疫疾病診斷市場的主要參與者包括Abbott Laboratories Inc.、Beckman Coulter Inc.、BioMeRieux SA、Bio-Rad Laboratories、F. Hoffmann-La、Roche Ltd.、Inova Diagnostics Inc.、Quest Diagnostics、SQI Diagnostics Inc .。本節包含競爭格局的整體視圖,包括各種策略發展,例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。
如果您有任何客製化要求,請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。
The global demand for Autoimmune Disease Diagnostics Market is presumed to reach the market size of nearly USD 19.35 Billion by 2032 from USD 13.2 Billion in 2023 with a CAGR of 4.34% under the study period 2024-2032.
The immune system offers protection to the body from many bacterial, viral infections, and other diseases. The autoimmune disorder is an unusual immune response occurring in the body. Autoimmune diseases reduce the body's ability to fight with the foreign particles resulting in attacking own body's tissues. The autoimmune disease is more common in women than men. Crohn's disease, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, systemic lupus erythematosus are some examples of autoimmune diseases. There are many tests commercially available at several healthcare centers to diagnose autoimmune disorders.
The global autoimmune disease diagnostics market is expected to grow due to increased government funding, a collaboration of clinics and diagnostics centers. In addition to this, the rise in the incidence of diseases such as rheumatoid arthritis, Graves, and Hashimoto's thyroid disease drives the growth of the market. Further, awareness about the various autoimmune diseases, advancements in medical fields, improved laboratory techniques, and others are also propelling the demand. However, high chances of false-positive results and slow turnaround time for diagnostic test results may hamper the market growth. Moreover, the developments in an emerging market, advancement in novel biomarkers for the prognosis of diseases are likely to offer new opportunities in market growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Autoimmune Disease Diagnostics. The growth and trends of Autoimmune Disease Diagnostics industry provide a holistic approach to this study.
This section of the Autoimmune Disease Diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Autoimmune Disease Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Autoimmune Disease Diagnostics market include Abbott Laboratories Inc., Beckman Coulter Inc., BioMeRieux SA, Bio-Rad Laboratories, F. Hoffmann-La, Roche Ltd., Inova Diagnostics Inc., Quest Diagnostics, SQI Diagnostics Inc. Siemens Healthcare Among Others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.